Paylocity
PCTY
148.02
+1.86
+1.27%
Paylocity
US · PCTY
#1707 by market cap
Listed 1970
148.02
+1.86
+1.27%
Live - 5344 symbols - heartbeat 199s ago
· 2026-10-08 08:32
Pre-market
148.00
-0.01%
After-hours
148.02
0.00%
Overnight
149.06
+0.70%
- Market cap
- 7.85B
- P/E (TTM)i
- 30.09
- P/Bi
- 6.43
- EPSi
- 4.92
- Div yieldi
- 0.00%
- 52W posi
- 80%
Reader sentiment
Are you bullish or bearish on PCTY?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.32, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +11.04% YoY
Margins
- Gross margin
- 69.19%
- Operating margin
- 21.79%
- Net margin
- 15.23%
Key ratios & quality
- Enterprise valuei
- 7.67B
- PEG ratioi
- 1.24
- Altman Z-Scorei
- 2.32
PEG uses trailing P/E against the 3-year net income growth rate (24.19%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 467.63M | 561.33M | 635.63M | 852.65M | 1.17B | 1.40B | 1.60B | 1.77B |
| Gross profit | 313.78M | 379.32M | 416.33M | 565.65M | 807.56M | 960.79M | 1.10B | 1.23B |
| Selling & admin expenses | 207.23M | 250.38M | 281.58M | 378.15M | 488.54M | 522.36M | 587.12M | 618.12M |
| Research & development | 50.33M | 62.77M | 76.71M | 102.91M | 163.99M | 178.33M | 205.85M | 221.39M |
| Operating profit | 56.22M | 66.17M | 58.04M | 84.59M | 155.03M | 260.09M | 304.02M | 385.99M |
| Pretax profit | 58.05M | 67.12M | 57.10M | 83.60M | 158.61M | 277.02M | 309.06M | 387.30M |
| Tax | 4.22M | 2.66M | -13.72M | -7.18M | 17.79M | 70.25M | 81.94M | 117.56M |
| Net profit | 53.82M | 64.46M | 70.82M | 90.78M | 140.82M | 206.77M | 227.13M | 269.74M |
| Basic EPS | 1 | 1 | 1 | 2 | 3 | 4 | 4 | 5 |
| Diluted EPS | 0.97 | 1.15 | 1.26 | 1.61 | 2.49 | 3.63 | 4.02 | 4.92 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 454.55M | 400.74M | 408.17M | 416.13M | 502.29M | 444.73M |
| Gross profit | 324.70M | 271.87M | 279.79M | 282.14M | 363.19M | 300.38M |
| Selling & admin expenses | 146.27M | 154.61M | 149.97M | 154.02M | 153.69M | 160.43M |
| Research & development | 51.40M | 51.04M | 55.61M | 57.74M | 52.52M | 55.53M |
| Operating profit | 127.03M | 66.23M | 74.21M | 70.38M | 156.98M | 84.42M |
| Pretax profit | 126.56M | 66.80M | 74.91M | 70.18M | 157.04M | 85.18M |
| Tax | 35.08M | 18.19M | 26.92M | 19.98M | 45.79M | 24.87M |
| Net profit | 91.48M | 48.61M | 47.99M | 50.20M | 111.25M | 60.30M |
| Basic EPS | 2 | 1 | 1 | 1 | 2 | 1 |
| Diluted EPS | 1.61 | 0.86 | 0.86 | 0.92 | 2.05 | 1.12 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.60B | 1.66B | 2.03B | 4.23B | 3.05B | 3.52B | 3.31B | 3.72B |
| Cash & ST investments | 161.79M | 285.41M | 206.74M | 139.76M | 288.77M | 401.81M | 398.07M | 271.92M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 1.80B | 1.99B | 2.41B | 4.81B | 3.70B | 4.25B | 4.39B | 4.88B |
| Total current liabilities | 1.46B | 1.41B | 1.87B | 4.12B | 2.77B | 3.12B | 2.91B | 3.42B |
| Short-term debt | 1.48M | 8.08M | 7.55M | 8.40M | 7.80M | 7.63M | 8.62M | 9.52M |
| Long-term debt | -- | 100.00M | -- | -- | -- | -- | 162.50M | 81.25M |
| Total liabilities | 1,495,977,000.00 | 1,592,740,000.00 | 1,937,955,000.00 | 4,195,551,000.00 | 2,852,817,000.00 | 3,212,396,000.00 | 3,155,681,000.00 | 3,662,941,000.00 |
| Total equity | 307.96M | 392.91M | 476.93M | 613.46M | 842.86M | 1.03B | 1.23B | 1.22B |
| Retained earnings | 99.82M | 164.27M | 235.09M | 325.87M | 466.69M | 673.46M | 900.58M | 1.17B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 4.10B | 3.31B | 3.16B | 5.89B | 4.36B | 3.72B |
| Cash & ST investments | 477.79M | 398.07M | 165.19M | 162.50M | 299.73M | 271.92M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 5.17B | 4.39B | 4.24B | 6.97B | 5.44B | 4.88B |
| Total current liabilities | 3.62B | 2.91B | 2.95B | 5.68B | 4.04B | 3.42B |
| Short-term debt | 8.24M | 8.62M | 8.06M | 8.19M | 9.37M | 9.52M |
| Long-term debt | 243.75M | 162.50M | 81.25M | 81.25M | 81.25M | 81.25M |
| Total liabilities | 3,959,231,000.00 | 3,155,681,000.00 | 3,132,653,000.00 | 5,874,469,000.00 | 4,263,641,000.00 | 3,662,941,000.00 |
| Total equity | 1.21B | 1.23B | 1.10B | 1.10B | 1.18B | 1.22B |
| Retained earnings | 851.98M | 900.58M | 948.57M | 998.77M | 1.11B | 1.17B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 115.03M | 112.66M | 124.85M | 155.05M | 282.72M | 384.67M | 418.23M | 533.25M |
| Depreciation & amortization | 34.56M | 37.91M | 42.97M | 50.22M | 60.87M | 76.43M | 99.64M | 111.80M |
| Free cash flow | 83.61M | 70.36M | 86.80M | 102.47M | 215.81M | 305.92M | 342.75M | 427.80M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -34.99M | -- | -- | 0 | 0 | -150.00M | -149.64M | -398.11M |
| Ending cash balance | 1.43B | 1.49B | 1.95B | 3.79B | 2.42B | 2.85B | 2.48B | 2.87B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 186.00M | 86.57M | 86.46M | 117.00M | 217.90M | 111.89M |
| Depreciation & amortization | 25.97M | 26.45M | 27.45M | 27.80M | 27.30M | 29.24M |
| Free cash flow | 167.72M | 64.28M | 67.20M | 97.70M | 191.85M | 71.06M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -82.69M | -58.56M | -200.00M | -100.00M | -50.00M | -48.11M |
| Ending cash balance | 3.39B | 2.48B | 2.32B | 5.06B | 3.53B | 2.87B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 20.67 | 18.39 | 16.28 | 16.65 | 19.34 | 22.04 | 20.04 | 21.97 |
| ROA %i | 3.25 | 3.40 | 3.22 | 2.51 | 3.31 | 5.21 | 5.26 | 5.82 |
| ROIC %i | 20.53 | 12.20 | 12.58 | 14.61 | 17.56 | 20.67 | 17.89 | 19.23 |
| 5-year avg ROE %i | 5.93 | 12.42 | 16.36 | 18.68 | 18.27 | 18.54 | 18.87 | 20.01 |
| EBIT margin %i | 12.02 | 11.79 | 9.13 | 9.92 | 13.20 | 18.54 | 19.06 | 21.79 |
| FCF / sales %i | 17.88 | 12.53 | 13.66 | 12.02 | 18.37 | 21.81 | 21.49 | 24.15 |
| Current ratioi | 1.10 | 1.18 | 1.09 | 1.03 | 1.10 | 1.13 | 1.14 | 1.09 |
| Quick ratioi | 0.11 | 0.21 | 0.11 | 0.04 | 0.11 | 0.14 | 0.15 | 0.09 |
| Debt / assetsi | 0.08 | 9.13 | 3.10 | 1.61 | 1.90 | 1.28 | 4.96 | 2.72 |
| LT debt / equityi | -- | 44.11 | 14.09 | 11.27 | 7.41 | 4.53 | 16.96 | 10.11 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 26.56 | 23.22 | 18.96 | 22.17 | 27.91 | 30.19 | 23.22 | 14.68 |
| Net income CAGR (3Y) %i | -- | 112.49 | 22.42 | 19.03 | 29.76 | 42.93 | 35.76 | 24.19 |
| FCF CAGR (3Y) %i | 114.10 | 37.61 | 12.75 | 7.02 | 45.29 | 52.18 | 49.55 | 25.62 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 19.70 | 20.04 | 20.42 | 20.99 | 21.60 | 21.97 |
| ROA %i | 4.49 | 5.26 | 5.46 | 3.89 | 4.86 | 5.82 |
| ROIC %i | 17.05 | 17.89 | 16.56 | 17.10 | 18.27 | 19.23 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 19.38 | 19.06 | 19.15 | 20.12 | 21.29 | 21.79 |
| FCF / sales %i | 21.64 | 21.49 | 20.48 | 23.63 | 24.37 | 24.15 |
| Current ratioi | 1.13 | 1.14 | 1.07 | 1.04 | 1.08 | 1.09 |
| Quick ratioi | 0.14 | 0.15 | 0.07 | 0.04 | 0.09 | 0.09 |
| Debt / assetsi | 5.82 | 4.96 | 3.20 | 1.91 | 2.47 | 2.72 |
| LT debt / equityi | 24.22 | 16.96 | 11.55 | 11.41 | 10.60 | 10.11 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Region
United States100.00%
Quote time 2026-10-08 08:32:17 · For reference only, not investment advice and not tailored to your situation.